FHC
ALXN

First Horizon Corporation’s Alexion Pharmaceuticals ALXN Stock Holding History

First Horizon Corporation’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$7K Buy
43
+1
+2% +$172 ﹤0.01% 796
2021
Q1 		$6K Hold
42
– – ﹤0.01% 821
2020
Q4 		$6K Hold
42
– – ﹤0.01% 788
2020
Q3 		$4K Buy
+42
New +$4.53K ﹤0.01% 830

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

First Horizon Corporation's ALXN Position: Q2 2021 in Review

First Horizon Corporation increased its Alexion Pharmaceuticals (ALXN) stake by 2.4% in Q2 2021, buying an estimated $172 and bringing the position to 43 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

First Horizon Corporation first reported a position in ALXN in Q3 2020 and has held it in 4 quarters since. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • First Horizon Corporation held 43 shares of Alexion Pharmaceuticals worth $7K as of Q2 2021.
  • First Horizon Corporation bought 1 Alexion Pharmaceuticals share in Q2 2021, an estimated $172.
  • Alexion Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #796 holding.
  • First Horizon Corporation first reported a position in Alexion Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.